全文获取类型
收费全文 | 14701篇 |
免费 | 963篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 173篇 |
儿科学 | 465篇 |
妇产科学 | 171篇 |
基础医学 | 2182篇 |
口腔科学 | 291篇 |
临床医学 | 1370篇 |
内科学 | 2913篇 |
皮肤病学 | 399篇 |
神经病学 | 1238篇 |
特种医学 | 613篇 |
外国民族医学 | 2篇 |
外科学 | 2186篇 |
综合类 | 151篇 |
一般理论 | 13篇 |
预防医学 | 1153篇 |
眼科学 | 601篇 |
药学 | 915篇 |
中国医学 | 14篇 |
肿瘤学 | 848篇 |
出版年
2022年 | 110篇 |
2021年 | 230篇 |
2020年 | 134篇 |
2019年 | 196篇 |
2018年 | 238篇 |
2017年 | 178篇 |
2016年 | 227篇 |
2015年 | 282篇 |
2014年 | 386篇 |
2013年 | 571篇 |
2012年 | 743篇 |
2011年 | 912篇 |
2010年 | 450篇 |
2009年 | 408篇 |
2008年 | 780篇 |
2007年 | 867篇 |
2006年 | 815篇 |
2005年 | 794篇 |
2004年 | 783篇 |
2003年 | 766篇 |
2002年 | 758篇 |
2001年 | 301篇 |
2000年 | 314篇 |
1999年 | 269篇 |
1998年 | 173篇 |
1997年 | 137篇 |
1996年 | 114篇 |
1995年 | 126篇 |
1994年 | 111篇 |
1993年 | 113篇 |
1992年 | 149篇 |
1991年 | 162篇 |
1990年 | 158篇 |
1989年 | 135篇 |
1988年 | 155篇 |
1987年 | 166篇 |
1986年 | 161篇 |
1985年 | 159篇 |
1984年 | 154篇 |
1983年 | 147篇 |
1982年 | 131篇 |
1981年 | 118篇 |
1980年 | 101篇 |
1979年 | 108篇 |
1978年 | 114篇 |
1977年 | 93篇 |
1976年 | 83篇 |
1974年 | 90篇 |
1973年 | 102篇 |
1972年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Sirt5 is known to functionally regulate mitochondrial proteins by altering posttranslational modifications, including lysine desuccinylation. While roles for Sirt5 as either a tumor promoter or suppressor, or in chemoresistance, have been implicated in other cancers, the function of Sirt5 in cutaneous melanoma has not been well examined. Therefore, to determine whether Sirt5 is necessary for BrafV600E‐mediated melanoma formation and/or disease progression, we crossed a genetically engineered murine melanoma model (TyrCreERT2/+; BrafLSL‐V600E/+; Ptenflox/flox) to Sirt5?/? knockout animals. In addition, we tested for synergism with a selective BRAF (V600E) inhibitor in Sirt5?/? mouse melanoma cells. Taken together, this report demonstrates that, in these models, Sirt5 is dispensable for BrafV600E‐mediated cutaneous melanoma formation and growth in vivo, and does not improve sensitivity to a selective BRAF inhibitor. 相似文献
5.
Jerry A. Shields Ralph C. Eagle Jr Carol L Shields Brian P. Marr 李学民 《美国医学会眼科杂志(中文版)》2006,18(1):33-39
众所周知,视网膜星形细胞瘤常伴有结节性硬化的表现。视网膜星形细胞瘤一般是发生在视网膜神经纤维层的无蒂轻度隆起性病变。临床上可以是单侧发生,也可以是双侧发生。可以单个病灶,也可以多个病灶。可以是透明的,也可以是不透明的。可以有钙化,也可以没有钙化。视网膜星形细胞瘤相对固定的伴有眼内结节性硬化,很少表现为浸润性增长。在很少的情况下视网膜星形细胞瘤可以表现出浸润性增长,造成局部严重并发症。 相似文献
6.
Oil-emulsified (OE) and aqueous (Aq) vaccines were prepared with the same batch of inactivated A24 8345 foot and mouth disease virus (FMDV). Calves born to vaccinated dams did not respond to the Aq vaccine 30 or 90 days post partum. When the OE vaccine was used on a similar group of calves, no responses were elicited up to 21 days post partum. However, calves 30 or more days old responded like adult cattle to the OE vaccine. When the OE vaccine was used in colostral antibody-free calves 3-30 days old, all animals showed good antibody responses but, in calves vaccinated 3 or 7 days post partum, antibodies were detectable only after a considerable period of time. Our results show that both passively acquired colostral antibodies and age are important in the response of very young calves to FMDV oil vaccines. From a practical point of view, in endemic areas where adult cattle are periodically vaccinated, vaccination of calves between 30 and 60 days post partum with OE vaccines would lead to high levels of herd protection. 相似文献
7.
The Resource-Based Relative Value Scale. Toward the development of an alternative physician payment system 总被引:2,自引:0,他引:2
This article describes the design and methods of a study currently under way to develop a Resource-Based Relative Value Scale (RBRVS); an alternative basis for establishing the payment rate for the services and procedures (S/Ps) of physicians in medical and surgical specialties. Physician resource inputs to be measured include (1) S/P time, (2) pre-S/P and post-S/P times, (3) intensity, (4) practice costs, including malpractice premiums, and (5) the cost of specialty training. These five factors will be combined to produce an RBRVS denominated in nonmonetary units. In the initial phase of the study, data on time and intensity will be obtained through a national survey of physicians who perform these S/Ps. In the second, consensus phase of the project, the investigators will convene a panel of representatives of the medical profession, third-party payers, consumers, and other interested parties to examine areas of agreement and disagreement as to how an RBRVS should be used for policy purposes. The final results of this study are expected by the summer of 1988. 相似文献
8.
9.
10.